| The Lescol Intervention Prevention Study (LIPS): start all patients on statins early after PCI. | |
| | |
MedLine Citation:
|
PMID: 12828227 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Lescol Intervention Prevention Study (LIPS) was the first randomized trial to show a significant reduction in the risk of cardiac events in patients started on fluvastatin immediately after a successful percutaneous coronary intervention. The benefit was independent of baseline cholesterol levels. The results suggest that all patients should be discharged on lipid-lowering therapy after a percutaneous coronary intervention. Currently, this is seldom done. |
| | |
Authors:
|
Adrian W Messerli; Herbert D Aronow; Dennis L Sprecher |
Related Documents
:
|
23478557 - Electrocardiographic findings suggestive of cardiomyopathy: what to look for and what t... 19782257 - Relationship between plaque composition and no-reflow phenomenon following primary angi... 23508287 - Unusual polymorphic ventricular tachycardia originating from the pulmonary artery. 20516507 - Influence of age on long-term outcome after emergent percutaneous coronary intervention... 21713377 - Coronary flow reserve varies depending upon the location within the artery it is assess... 8723597 - Acute hemodynamic deterioration during rapid atrial pacing in patients with hypertrophi... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: Cleveland Clinic journal of medicine Volume: 70 ISSN: 0891-1150 ISO Abbreviation: Cleve Clin J Med Publication Date: 2003 Jun |
Date Detail:
|
Created Date: 2003-06-27 Completed Date: 2003-08-04 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8703441 Medline TA: Cleve Clin J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 561-6 Citation Subset: IM |
Affiliation:
|
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Coronary Artery Disease / drug therapy* Double-Blind Method Fatty Acids, Monounsaturated / therapeutic use* Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use* Indoles / therapeutic use* Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Acids, Monounsaturated; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Indoles; 93957-54-1/fluvastatin |
| Comments/Corrections | |
Comment In:
|
Cleve Clin J Med. 2003 Jun;70(6):502, 504-6
[PMID:
12828221
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Raising an isolated low HDL-C level: why, how, and when?
Next Document: Predicting adolescent pedestrians' road-crossing intentions: an application and extension of the The...